204 related articles for article (PubMed ID: 24752924)
1. Analysis of Parkinson's disease brain-derived DNA for alpha-synuclein coding somatic mutations.
Proukakis C; Shoaee M; Morris J; Brier T; Kara E; Sheerin UM; Charlesworth G; Tolosa E; Houlden H; Wood NW; Schapira AH
Mov Disord; 2014 Jul; 29(8):1060-4. PubMed ID: 24752924
[TBL] [Abstract][Full Text] [Related]
2. Somatic alpha-synuclein mutations in Parkinson's disease: hypothesis and preliminary data.
Proukakis C; Houlden H; Schapira AH
Mov Disord; 2013 Jun; 28(6):705-12. PubMed ID: 23674490
[TBL] [Abstract][Full Text] [Related]
3. Somatic copy number gains of α-synuclein (SNCA) in Parkinson's disease and multiple system atrophy brains.
Mokretar K; Pease D; Taanman JW; Soenmez A; Ejaz A; Lashley T; Ling H; Gentleman S; Houlden H; Holton JL; Schapira AHV; Nacheva E; Proukakis C
Brain; 2018 Aug; 141(8):2419-2431. PubMed ID: 29917054
[TBL] [Abstract][Full Text] [Related]
4. Alpha-synuclein dynamics in induced pluripotent stem cell-derived dopaminergic neurons from a Parkinson's disease patient (PARK4) with SNCA triplication.
Fukusumi H; Togo K; Sumida M; Nakamori M; Obika S; Baba K; Shofuda T; Ito D; Okano H; Mochizuki H; Kanemura Y
FEBS Open Bio; 2021 Feb; 11(2):354-366. PubMed ID: 33301617
[TBL] [Abstract][Full Text] [Related]
5. α-Synuclein BAC transgenic mice exhibit RBD-like behaviour and hyposmia: a prodromal Parkinson's disease model.
Taguchi T; Ikuno M; Hondo M; Parajuli LK; Taguchi K; Ueda J; Sawamura M; Okuda S; Nakanishi E; Hara J; Uemura N; Hatanaka Y; Ayaki T; Matsuzawa S; Tanaka M; El-Agnaf OMA; Koike M; Yanagisawa M; Uemura MT; Yamakado H; Takahashi R
Brain; 2020 Jan; 143(1):249-265. PubMed ID: 31816026
[TBL] [Abstract][Full Text] [Related]
6. Expression Levels of an Alpha-Synuclein Transcript in Blood May Distinguish between Early Dementia with Lewy Bodies and Parkinson's Disease.
Marsal-García L; Urbizu A; Arnaldo L; Campdelacreu J; Vilas D; Ispierto L; Gascón-Bayarri J; Reñé R; Álvarez R; Beyer K
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33450872
[TBL] [Abstract][Full Text] [Related]
7. The role of alpha-synuclein gene multiplications in early-onset Parkinson's disease and dementia with Lewy bodies.
Hofer A; Berg D; Asmus F; Niwar M; Ransmayr G; Riemenschneider M; Bonelli SB; Steffelbauer M; Ceballos-Baumann A; Haussermann P; Behnke S; Krüger R; Prestel J; Sharma M; Zimprich A; Riess O; Gasser T
J Neural Transm (Vienna); 2005 Sep; 112(9):1249-54. PubMed ID: 15622440
[TBL] [Abstract][Full Text] [Related]
8. Investigation of somatic CNVs in brains of synucleinopathy cases using targeted SNCA analysis and single cell sequencing.
Perez-Rodriguez D; Kalyva M; Leija-Salazar M; Lashley T; Tarabichi M; Chelban V; Gentleman S; Schottlaender L; Franklin H; Vasmatzis G; Houlden H; Schapira AHV; Warner TT; Holton JL; Jaunmuktane Z; Proukakis C
Acta Neuropathol Commun; 2019 Dec; 7(1):219. PubMed ID: 31870437
[TBL] [Abstract][Full Text] [Related]
9. α-synuclein genetic variability: A biomarker for dementia in Parkinson disease.
Guella I; Evans DM; Szu-Tu C; Nosova E; Bortnick SF; ; Goldman JG; Dalrymple-Alford JC; Geurtsen GJ; Litvan I; Ross OA; Middleton LT; Parkkinen L; Farrer MJ
Ann Neurol; 2016 Jun; 79(6):991-9. PubMed ID: 27091628
[TBL] [Abstract][Full Text] [Related]
10. Path mediation analysis reveals GBA impacts Lewy body disease status by increasing α-synuclein levels.
Gündner AL; Duran-Pacheco G; Zimmermann S; Ruf I; Moors T; Baumann K; Jagasia R; van de Berg WDJ; Kremer T
Neurobiol Dis; 2019 Jan; 121():205-213. PubMed ID: 30236861
[TBL] [Abstract][Full Text] [Related]
11. Genetic analysis of α-synuclein 3' untranslated region and its corresponding microRNAs in relation to Parkinson's disease compared to dementia with Lewy bodies.
Tagliafierro L; Glenn OC; Zamora ME; Beach TG; Woltjer RL; Lutz MW; Chiba-Falek O
Alzheimers Dement; 2017 Nov; 13(11):1237-1250. PubMed ID: 28431219
[TBL] [Abstract][Full Text] [Related]
12. Alpha-synuclein transcript isoforms in three different brain regions from Parkinson's disease and healthy subjects in relation to the SNCA rs356165/rs11931074 polymorphisms.
Cardo LF; Coto E; de Mena L; Ribacoba R; Mata IF; Menéndez M; Moris G; Alvarez V
Neurosci Lett; 2014 Mar; 562():45-9. PubMed ID: 24418406
[TBL] [Abstract][Full Text] [Related]
13. INDEL Length and Haplotypes in the β-Synuclein Gene: A Key to Differentiate Dementia with Lewy Bodies?
Gámez-Valero A; Canet-Pons J; Urbizu A; Anillo A; Santos C; Ariza A; Beyer K
J Alzheimers Dis; 2018; 65(1):207-219. PubMed ID: 30040713
[TBL] [Abstract][Full Text] [Related]
14. Levels of alpha-synuclein mRNA in sporadic Parkinson disease patients.
Chiba-Falek O; Lopez GJ; Nussbaum RL
Mov Disord; 2006 Oct; 21(10):1703-8. PubMed ID: 16795004
[TBL] [Abstract][Full Text] [Related]
15. α-Synuclein mRNA and soluble α-synuclein protein levels in post-mortem brain from patients with Parkinson's disease, dementia with Lewy bodies, and Alzheimer's disease.
Quinn JG; Coulson DT; Brockbank S; Beyer N; Ravid R; Hellemans J; Irvine GB; Johnston JA
Brain Res; 2012 Jun; 1459():71-80. PubMed ID: 22560502
[TBL] [Abstract][Full Text] [Related]
16. Selective loss of glucocerebrosidase activity in sporadic Parkinson's disease and dementia with Lewy bodies.
Chiasserini D; Paciotti S; Eusebi P; Persichetti E; Tasegian A; Kurzawa-Akanbi M; Chinnery PF; Morris CM; Calabresi P; Parnetti L; Beccari T
Mol Neurodegener; 2015 Mar; 10():15. PubMed ID: 25881142
[TBL] [Abstract][Full Text] [Related]
17. [Clinical and pathological study on early diagnosis of Parkinson's disease and dementia with Lewy bodies].
Orimo S
Rinsho Shinkeigaku; 2008 Jan; 48(1):11-24. PubMed ID: 18386627
[TBL] [Abstract][Full Text] [Related]
18. α-synuclein expression from a single copy transgene increases sensitivity to stress and accelerates neuronal loss in genetic models of Parkinson's disease.
Cooper JF; Spielbauer KK; Senchuk MM; Nadarajan S; Colaiácovo MP; Van Raamsdonk JM
Exp Neurol; 2018 Dec; 310():58-69. PubMed ID: 30194957
[TBL] [Abstract][Full Text] [Related]
19. Alteration in alpha-synuclein mRNA expression in Parkinson's disease.
Kingsbury AE; Daniel SE; Sangha H; Eisen S; Lees AJ; Foster OJ
Mov Disord; 2004 Feb; 19(2):162-70. PubMed ID: 14978671
[TBL] [Abstract][Full Text] [Related]
20. Pathological biochemistry of alpha-synucleinopathy.
Iwatsubo T
Neuropathology; 2007 Oct; 27(5):474-8. PubMed ID: 18018483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
